Shionogi & Co., Ltd. (TYO:4507)

Market Cap	2.22T
Revenue (ttm)	437.30B
Net Income (ttm)	170.81B
Shares Out	850.98M
EPS (ttm)	200.72
PE Ratio	12.99
Forward PE	11.77
Dividend	66.00 (2.53%)
Ex-Dividend Date	Mar 30, 2026

Volume	1,725,500
Average Volume	3,108,900
Open	2,605.00
Previous Close	2,624.00
Day's Range	2,595.00 - 2,630.00
52-Week Range	2,055.00 - 2,758.00
Beta	-0.09
RSI	60.76
Earnings Date	Oct 27, 2025

About Shionogi &

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1878
• Employees: 4,955
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4507

Financial Performance

In 2024, Shionogi &'s revenue was 438.27 billion, an increase of 0.73% compared to the previous year's 435.08 billion. Earnings were 170.44 billion, an increase of 5.19%.